Figure 1: Three-dimensional structure of filgrastim (G-CSF) and IgG1 (e.g. rituximab).
From: Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies
From: Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies